Oppenheimer & CO Inc Laboratory Corp Of America Holdings Transaction History

Oppenheimer & CO Inc

$6.52 Billion
Q4 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$209.01 - $232.56 $12,331 - $13,721	59 Added 2.18%	2,771 $605,000
Q4 2023 Feb 13, 2024	SELL	$197.69 - $227.29 $8,302 - $9,546	-42 Reduced 1.53%	2,712 $616,000
Q3 2023 Nov 07, 2023	BUY	$201.05 - $221.7 $38,199 - $42,123	190 Added 7.41%	2,754 $553,000
Q2 2023 Aug 02, 2023	SELL	$211.93 - $241.33 $205,360 - $233,848	-969 Reduced 27.43%	2,564 $618,000
Q1 2023 May 10, 2023	SELL	$213.32 - $257.83 $286,915 - $346,781	-1,345 Reduced 27.57%	3,533 $810,000
Q4 2022 Feb 07, 2023	SELL	$203.72 - $248.97 $425,367 - $519,849	-2,088 Reduced 29.97%	4,878 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $19,252 - $24,645	94 Added 1.37%	6,966 $1.43 Million
Q2 2022 Aug 08, 2022	BUY	$213.86 - $277.87 $201,456 - $261,753	942 Added 15.89%	6,872 $1.61 Million
Q1 2022 May 12, 2022	BUY	$259.82 - $298.18 $435,458 - $499,749	1,676 Added 39.4%	5,930 $1.56 Million
Q4 2021 Feb 02, 2022	BUY	$271.6 - $314.21 $30,962 - $35,819	114 Added 2.75%	4,254 $1.34 Million
Q3 2021 Nov 12, 2021	BUY	$274.82 - $308.34 $70,079 - $78,626	255 Added 6.56%	4,140 $1.17 Million
Q2 2021 Aug 03, 2021	BUY	$251.87 - $278.14 $22,416 - $24,754	89 Added 2.34%	3,885 $1.07 Million
Q1 2021 May 10, 2021	BUY	$204.88 - $255.03 $3,482 - $4,335	17 Added 0.45%	3,796 $968,000
Q4 2020 Feb 11, 2021	SELL	$186.91 - $214.42 $320,550 - $367,730	-1,715 Reduced 31.22%	3,779 $769,000
Q3 2020 Nov 13, 2020	BUY	$167.03 - $201.3 $16,034 - $19,324	96 Added 1.78%	5,494 $1.03 Million
Q2 2020 Aug 11, 2020	BUY	$113.31 - $182.44 $246,335 - $396,624	2,174 Added 67.43%	5,398 $896,000
Q1 2020 May 08, 2020	BUY	$104.32 - $195.28 $71,354 - $133,571	684 Added 26.93%	3,224 $408,000
Q4 2019 Feb 07, 2020	BUY	$163.48 - $173.61 $117,705 - $124,999	720 Added 39.56%	2,540 $430,000
Q3 2019 Oct 31, 2019	BUY	$159.77 - $178.1 $1,278 - $1,424	8 Added 0.44%	1,820 $306,000
Q1 2019 Apr 24, 2019	SELL	$123.7 - $156.3 $16,081 - $20,319	-130 Reduced 6.69%	1,812 $277,000
Q4 2018 Jan 29, 2019	SELL	$120.82 - $174.09 $97,139 - $139,968	-804 Reduced 29.28%	1,942 $245,000
Q3 2018 Oct 26, 2018	SELL	$167.67 - $188.27 $28,671 - $32,194	-171 Reduced 5.86%	2,746 $477,000
Q2 2018 Aug 10, 2018	BUY	$160.33 - $189.41 $76,958 - $90,916	480 Added 19.7%	2,917 $524,000
Q1 2018 May 01, 2018	BUY	$161.53 - $178.11 $4,199 - $4,630	26 Added 1.08%	2,437 $394,000
Q4 2017 Feb 07, 2018	BUY	$147.99 - $163.95 $11,839 - $13,116	80 Added 3.43%	2,411 $385,000
Q3 2017 Nov 09, 2017	BUY	$149.47 - $160.56 $348,414 - $374,265	2,331	2,331 $352,000

Others Institutions Holding LH

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account